Bank of New York Mellon’s Microbot Medical MBOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-51,346
| Closed | -$71.4K | – | 4353 |
|
|
2023
Q3 | $71.4K | Sell |
51,346
-1,392
| -3% | -$3.02K | ﹤0.01% | 4131 |
|
|
2023
Q2 | $143K | Buy |
52,738
+37,346
| +243% | +$74.8K | ﹤0.01% | 4039 |
|
|
2023
Q1 | $32K | Sell |
15,392
-150
| -1% | -$444 | ﹤0.01% | 4257 |
|
|
2022
Q4 | $46.8K | Sell |
15,542
-116
| -0.7% | -$481 | ﹤0.01% | 4247 |
|
|
2022
Q3 | $75K | Buy |
15,658
+150
| +1% | +$771 | ﹤0.01% | 4251 |
|
|
2022
Q2 | $80K | Sell |
15,508
-102
| -0.7% | -$568 | ﹤0.01% | 4275 |
|
|
2022
Q1 | $98K | Hold |
15,610
| – | – | ﹤0.01% | 4407 |
|
|
2021
Q4 | $117K | Hold |
15,610
| – | – | ﹤0.01% | 4381 |
|
|
2021
Q3 | $110K | Hold |
15,610
| – | – | ﹤0.01% | 4317 |
|
|
2021
Q2 | $124K | Sell |
15,610
-2,749
| -15% | -$20.8K | ﹤0.01% | 4184 |
|
|
2021
Q1 | $156K | Sell |
18,359
-1,340
| -7% | -$11.5K | ﹤0.01% | 4106 |
|
|
2020
Q4 | $136K | Hold |
19,699
| – | – | ﹤0.01% | 4044 |
|
|
2020
Q3 | $150K | Buy |
19,699
+1
| +0% | +$7 | ﹤0.01% | 3906 |
|
|
2020
Q2 | $136K | Hold |
19,698
| – | – | ﹤0.01% | 3875 |
|
|
2020
Q1 | $109K | Sell |
19,698
-6,631
| -25% | -$58.1K | ﹤0.01% | 3846 |
|
|
2019
Q4 | $268K | Buy |
26,329
+1
| +0% | +$6 | ﹤0.01% | 3836 |
|
|
2019
Q3 | $140K | Buy |
26,328
+2
| +0% | +$12 | ﹤0.01% | 3971 |
|
|
2019
Q2 | $136K | Buy |
26,326
+2
| +0% | +$13 | ﹤0.01% | 3987 |
|
|
2019
Q1 | $204K | Buy |
+26,324
| New | +$205K | ﹤0.01% | 3882 |
|
|
2017
Q4 | – | Sell |
-878
| Closed | -$15K | – | 4380 |
|
|
2017
Q3 | $15K | Buy |
+878
| New | +$15.5K | ﹤0.01% | 4230 |
|
|
2016
Q2 | – | Sell |
-69
| Closed | -$29K | – | 4343 |
|
|
2016
Q1 | $29K | Hold |
69
| – | – | ﹤0.01% | 4144 |
|
|
2015
Q4 | $47K | Hold |
69
| – | – | ﹤0.01% | 4194 |
|
|
2015
Q3 | $45K | Hold |
69
| – | – | ﹤0.01% | 4254 |
|
|
2015
Q2 | $61K | Buy |
69
+7
| +11% | +$8.24K | ﹤0.01% | 4141 |
|
|
2015
Q1 | $102K | Buy |
62
+2
| +3% | +$3.57K | ﹤0.01% | 4036 |
|
|
2014
Q4 | $91K | Hold |
60
| – | – | ﹤0.01% | 4068 |
|
|
2014
Q3 | $122K | Sell |
60
-10
| -14% | -$26.4K | ﹤0.01% | 4000 |
|
|
2014
Q2 | $230K | Buy |
70
+47
| +204% | +$108K | ﹤0.01% | 3801 |
|
|
2014
Q1 | $49K | Buy |
23
+16
| +229% | +$38.3K | ﹤0.01% | 4078 |
|
|
2013
Q4 | $14K | Hold |
7
| – | – | ﹤0.01% | 4182 |
|
|
2013
Q3 | $19K | Hold |
7
| – | – | ﹤0.01% | 4117 |
|
|
2013
Q2 | $18K | Buy |
+7
| New | +$19.7K | ﹤0.01% | 4114 |
|
Other funds holding MBOT
AC
AA
HF
VF
Bank of New York Mellon's MBOT Position: Q4 2023 in Review
Bank of New York Mellon sold out of Microbot Medical (MBOT) in Q4 2023, closing a stake of 51,346 shares — an estimated $71.4K sold.
Bank of New York Mellon first reported a position in MBOT in Q2 2013 and held it in 32 quarters. The position peaked at $268K in Q4 2019. 36 funds tracked by Wall St. Rank hold MBOT as of Q4 2023.
- Bank of New York Mellon reported no remaining Microbot Medical position as of Q4 2023 after selling out during the quarter.
- Bank of New York Mellon sold 51,346 Microbot Medical shares in Q4 2023, an estimated $71.4K.
- Bank of New York Mellon first reported a position in Microbot Medical in Q2 2013 and held it in 32 quarters.
- Bank of New York Mellon's Microbot Medical position peaked at $268K in Q4 2019.
- 36 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2023.
Based on Bank of New York Mellon's 13F filing for Q4 2023, filed 29 Jan 2024.